Tag Archives: monopoly medicine company in india

India to Become Global Hub for Single-Pill Drugs by 2030

India Emerges as a Global Hub for Single-Pill Combination Drugs, Targeting €500 Million Exports by 2030

India’s pharmaceutical sector continues to strengthen its position as a global powerhouse. In a significant strat […]

Read More
Biopharma Shakti: India’s Strategy to Cut China Dependence & Lead Biosimilars

India Targets China Dependence and the Global Patent Cliff

India’s pharmaceutical landscape is entering a decisive transformation phase with the launch of […]

Read More
Patent Rejection Clears Path for Affordable Cancer Medicines in India

Patent Rejection Opens the Door for Affordable Cancer Treatment in India

India’s pharmaceutical and healthcare ecosystem has once again demonstrated its strong stance on patient-centric i […]

Read More
Indian Pharma Industry Gets a Fresh Boost as Government Pushes Manufacturing and Export Growth

Indian Pharma Industry Gets a Fresh Boost as Government Pushes Manufacturing and Export Growth

The Indian pharmaceutical industry has witnessed a significant policy-drive […]

Read More
Delhi High Court, diabetes FDC ban, Type II Diabetes Mellitus, fixed dose combination drugs, Glimepiride Pioglitazone Metformin, Drugs and Cosmetics Act 1940, Section 26A, DTAB recommendations, pharma regulatory news India, Indian pharmaceutical industry, drug safety regulations, anti-diabetic medicines, pharma manufacturing India, monopoly medicine company in India, pharma contract manufacturing company

Delhi High Court Restores Ban on Certain Type II Diabetes FDCs: Legal, Regulatory, and Industry Implications

[…]

Read More
Budget for 'pharmacy of the world'

Union Budget 2026: Strengthening India’s Vision as the “Pharmacy of the World”

India has steadily earned its reputation as the “Pharmacy of the World” […]

Read More
counterfeit rabies vaccine india, rabies vaccine alert india, fake rabies vaccine, vaccine safety india, pharmaceutical quality control india

Counterfeit Rabies Vaccine Alert: What It Means for India’s Vaccine Safety Ecosystem

Recent developments in the global immunisation landscape have brought renewed attention to vaccine safety, regulato […]

Read More
Import Floor Price on APIs: Boosting India’s Pharma Security

Import Floor Price on APIs: A Strategic Step Toward Self-Reliant and Secure Indian Pharma

India’s pharmaceutical sector is entering a decisive phase as the government introduces a […]

Read More
WHO GMP Company for PCD Franchise | Best Pharma Franchise in India

WHO GMP Company for PCD Franchise: Best Opportunity to Start a Profitable Pharma Business in India

The Indian pharmaceutical industry is witnessing a sharp rise in demand for […]

Read More
Digital Is No Longer a Choice: Why Indian Pharma Must Invest Now to Stay Competitive

Digital Is No Longer a Choice: Why Indian Pharma Must Invest Now to Stay Competitive

The Indian pharmaceutical industry is undergoing the most significant transformation in its history. What was once […]

Read More